Dr. Kevin Bielamowicz, MD
Claim this profileArkansas Children's Hospital
Studies Neuroblastoma
Studies Childhood Cancer
13 reported clinical trials
24 drugs studied
Area of expertise
1Neuroblastoma
MYC positive
2Childhood Cancer
BCR-ABL1 positive
BCR-ABL1 T315I positive
IGH-TCR PCR positive
Affiliated Hospitals
Clinical Trials Kevin Bielamowicz, MD is currently running
DFMO
for Medulloblastoma
Difluoromethylornithine (DFMO) will be used in an open label, multicenter, study as Maintenance Therapy for Molecular High Risk/Very High Risk and Relapsed/Refractory Medulloblastoma.
Recruiting1 award Phase 2
DFMO + Etoposide
for Neuroblastoma
This trial uses two drugs, DFMO and etoposide, to treat children whose neuroblastoma has come back or didn't respond to initial treatments. DFMO stops cancer cells from growing, and etoposide helps kill them. The study includes patients who are recovering after additional therapy, those who have had the disease return but are currently without symptoms, and those with active disease. DFMO has been evaluated as a follow-up treatment for severe neuroblastoma in previous studies.
Recruiting1 award Phase 2
More about Kevin Bielamowicz, MD
Clinical Trial Related5 years of experience running clinical trials · Led 13 trials as a Principal Investigator · 9 Active Clinical TrialsTreatments Kevin Bielamowicz, MD has experience with
- Ceritinib
- Topotecan
- Talazoparib
- Gemcitabine
- Ponatinib
- Induction
Breakdown of trials Kevin Bielamowicz, MD has run
Neuroblastoma
Childhood Cancer
Acute Myeloid Leukemia
Acute Lymphoblastic Leukemia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Kevin Bielamowicz, MD specialize in?
Kevin Bielamowicz, MD focuses on Neuroblastoma and Childhood Cancer. In particular, much of their work with Neuroblastoma has involved MYC positive patients, or patients who are undergoing treatment.
Is Kevin Bielamowicz, MD currently recruiting for clinical trials?
Yes, Kevin Bielamowicz, MD is currently recruiting for 8 clinical trials in Little Rock Arkansas. If you're interested in participating, you should apply.
Are there any treatments that Kevin Bielamowicz, MD has studied deeply?
Yes, Kevin Bielamowicz, MD has studied treatments such as Ceritinib, Topotecan, Talazoparib.
What is the best way to schedule an appointment with Kevin Bielamowicz, MD?
Apply for one of the trials that Kevin Bielamowicz, MD is conducting.
What is the office address of Kevin Bielamowicz, MD?
The office of Kevin Bielamowicz, MD is located at: Arkansas Children's Hospital, Little Rock, Arkansas 72202 United States. This is the address for their practice at the Arkansas Children's Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.